Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00108160 · ClinicalTrials.gov registry record · Phase 4
Preventing Staphylococcal (Staph) Infection
A Phase 4 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 4
- Development phase
- 146
- Enrollment target
NCT00108160: Completed Phase 4 study, sponsored by US Department of Veterans Affairs.
NCT00108160 is a Phase 4 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 146 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (72% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00108160, a Phase 4 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 146 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if mupirocin 2% in polyethylene glycol (PEG) ointment \[Treatment Arm\] is effective in preventing moderate to severe re-infection with Staphylococcus aureus compared with treatment with polyethylene glycol (PEG) ointment \[Placebo Arm\].
Primary Outcome
During the study, patients with prior well-documented infections with Staphylococcus aureus who developed new signs and symptoms of infection, met standardized clinical criteria for infection, and had S. aureus isolated on culture were considered to have re-infection with S. aureus. The number of S. aureus re-infections were compared in the mupirocin ointment (Treatment Arm) versus polyethylene glycol ointment (Placebo Arm) for all participants enrolled in the study and in participants who compl
Interventions
- DRUG Mupirocin Ointment [Treatment]
- DRUG Polyethylene Glycol Ointment [Placebo]
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2005-04 |
| Est. Completion | 2012-08 |
| Phase | Phase 4 |
What the finished NCT00108160 record still lists
NCT00108160 is an interventional study that assigns participants to a tested intervention. The registered 146 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (72% lower).
The record links to 0 conditions, and to 2 interventions - of which Mupirocin Ointment [Treatment] is the first listed.
NCT00108160 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00108160 about?
NCT00108160 is a clinical study titled "Preventing Staphylococcal (Staph) Infection". The purpose of this study is to determine if mupirocin 2% in polyethylene glycol (PEG) ointment \[Treatment Arm\] is effective in preventing moderate to severe re-infection with Staphylococcus aureus compared with treatment with polyethylene glycol (PEG) ointment \[Placebo Arm\].
What is the current status of trial NCT00108160?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 146 participants. The study started on 2005-04. Estimated completion is 2012-08.
What interventions are being tested in trial NCT00108160?
The interventions under investigation include: Mupirocin Ointment [Treatment] (DRUG), Polyethylene Glycol Ointment [Placebo] (DRUG).
Who is sponsoring clinical trial NCT00108160?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00108160's enrollment target sits among peer trials
146 571st of 2000 higher than 1,428 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03490929 · 146 participants · Phase 4
CEUS for Blunt Abdominal Trauma in Children
- NCT04755062 · 146 participants · NA
A Culturally-relevant Micronutrient-dense Plant-rich (mNDPR) Dietary Intervention for Native Americans
- NCT04867954 · 146 participants
Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis
- NCT05051618 · 146 participants · NA
Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia